A randomized controlled trial for cervical priming using vaginal misoprostol prior to hysteroscopy in women who have only undergone cesarean section

被引:4
作者
Kalampokas, Emmanouil [1 ]
Sofoudis, Chrisostomos [1 ]
Antonogeorgos, George [2 ]
Panoulis, Konstantinos [1 ]
Aravantinos, Leon [1 ]
Grigoriou, Odysseas [1 ]
Kalampokas, Theodoros [1 ]
机构
[1] Univ Athens, Sch Med, Dept Obstet & Gynecol 2, GR-11527 Athens, Greece
[2] Harokopio Univ, Dept Sci Nutr & Dietet, Athens, Greece
关键词
Misoprostol; Hysteroscopy; Cesarean section; Cervical priming; Cervical dilatation; PLACEBO-CONTROLLED TRIAL; OPERATIVE HYSTEROSCOPY; DOUBLE-BLIND; OUTPATIENT HYSTEROSCOPY; ORAL MISOPROSTOL; DIAGNOSTIC HYSTEROSCOPY; PATIENT SATISFACTION; POSTMENOPAUSAL WOMEN; OFFICE HYSTEROSCOPY; CLINICAL-TRIAL;
D O I
10.1007/s00404-012-2374-7
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
To evaluate the efficacy of misoprostol administrated vaginally on cervical priming and its complications prior to diagnostic or operative hysteroscopy in women who have undergone at least one cesarean section and who have never delivered vaginally before and/or had other transcervical procedure. A total of 55 patients undergoing hysteroscopy for various intra-uterine lesions were included in this study and were randomly allocated to two groups finally. Thirty patients in the study group were given 200 mu g misoprostol vaginally 12 h before the procedure, whereas 25 patients in the control group did not receive any cervical priming. The countered outcome included the cervical width detected with Hegar dilatators and complication rates. Mean cervical width was greater in the study group (6.6 +/- A 1.3) than in the control group (5.1 +/- A 0.9). Complications and failure rates were lower in the study group. Application of 200 mu g misoprostol vaginally 12 h before hysteroscopy softens the cervix, reduces cervical resistance and consequently the need for cervical dilatation, with only mild side effects.
引用
收藏
页码:853 / 857
页数:5
相关论文
共 50 条
  • [31] Cervical ripening before operative hysteroscopy in premenopausal women: a randomized, double-blind, placebo-controlled comparison of vaginal and oral misoprostol
    Batukan, Cem
    Ozgun, Mahmut T.
    Ozcelik, Bulent
    Aygen, Ercan
    Sahin, Yilmaz
    Turkyilmaz, Cagdas
    FERTILITY AND STERILITY, 2008, 89 (04) : 966 - 973
  • [32] The efficacy of intrauterine misoprostol during cesarean section in prevention of primary PPH, a randomized controlled trial
    Alalfy, Mahmoud
    Lasheen, Yossra
    Elshenoufy, Hossam
    Elzahaby, I. M.
    Kaleem, Heba W.
    El Sawah, Heba
    Azkalani, Ahmed
    Saber, Waleed
    Rashwan, Ahmed S. S. A.
    JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE, 2020, 33 (09) : 1459 - 1465
  • [33] Oral versus vaginal misoprostol for cervical priming in first-trimester abortion:: a randomized trial
    Carbonell, JL
    Velazco, A
    Rodriguez, Y
    Tanda, R
    Sánchez, C
    Barambio, S
    Valera, L
    Chami, S
    Valero, F
    Aragón, S
    Marí, J
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2001, 6 (03) : 134 - 140
  • [34] Midtrimester abortion using vaginal misoprostol for women with three or more prior cesarean deliveries
    Fawzy, Muhammad
    Abdel-Hady, El-Said
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2010, 110 (01) : 50 - 52
  • [35] Sublingual versus vaginal misoprostol (400 μg) for cervical priming in first-trimester abortion:: a randomized trial
    Carbonell Esteve, Josep Lluis
    Mari, Jose Maria
    Valero, Francisco
    Llorente, Margardel
    Salvador, Immaculada
    Varela, Lidia
    Leal, Pedro
    Candel, Ana
    Tudela, Ana
    Serrano, Maria
    Munoz, Eva
    CONTRACEPTION, 2006, 74 (04) : 328 - 333
  • [36] Comparative Study of the Effects of Sublingual Trinitroglycerin and Sublingual Misoprostol on Cervical Preparation before Hysteroscopy: A Randomized Controlled Trial
    Mirgaloybayat, Shahla
    Madadian, Mahmoodreza
    Tahermanesh, Kobra
    Derakhshan, Roya
    Sarhadi, Saeedeh
    Rokhgireh, Samaneh
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2024, 51 (07)
  • [37] A randomised controlled trial of low-dose misoprostol and dinoprostone vaginal pessaries for cervical priming
    Tan, T-C
    Yan, S. Y.
    Chua, T. M.
    Biswas, A.
    Chong, Y-S
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2010, 117 (10) : 1270 - 1277
  • [38] Comparison of self-administered vaginal misoprostol versus placebo for cervical ripening prior to operative hysteroscopy using a sequential trial design
    Oppegaard, K. S.
    Nesheim, B-I
    Istre, O.
    Qvigstad, E.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2008, 115 (05) : 663 - E9
  • [39] Comparative efficacy of lidocaine-prilocaine cream and vaginal misoprostol in reducing pain during levonorgestrel intrauterine device insertion in women delivered only by cesarean delivery: A randomized controlled trial
    Hashem, Ahmed T.
    Mahmoud, Mostafa
    Aly Islam, Bassem
    Ibrahem Eid, Mohamed
    Ahmed, Nancy
    Mohamed Mamdouh, Ahmed
    Elkomy, Rasha
    Fouad Elgamel, Amira
    Hamada, A. A. Ali
    Khalil, Eman M.
    Ashour, Ahmed S. A.
    Said Ali, Ahmed
    Taher, Ayman
    Hasan Hussein, Amr
    Elzahaby, Iman
    Hafez Mohamed Younes, Mohamed
    Salah, Emad
    Mojahed, Eman M.
    Talaat, Bassem
    ElHodiby, Mohamed
    Kamal Osman, Nada
    Adel Nour, Dalia
    Khamis, Yasser
    Aly Hamed Elsallamy, Ayman
    Ahmed Gehad, Mahmoud
    Kotb, Mohamed Mahmoud Mohamed
    Gad Allah, Sherine H.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2024, 165 (02) : 634 - 643
  • [40] Effectiveness of Vaginal Misoprostol and Rectal Nonsteroidal Anti-Inflammatory Drug in Vaginoscopic Diagnostic Outpatient Hysteroscopy in Primarily Infertile Women: Double-Blind, Randomized, Controlled Trial
    Hassa, Hikmet
    Aydin, Yunus
    Oge, Tufan
    Cicek, Kiymet
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2013, 20 (06) : 880 - 885